IDH1 mutant enzyme does not affect glucose labeling of nucleotide precursors. Cells were treated and analyzed as described for Supporting Figure S4 in order to determine the percent labeling of nucleotide precursors. There is no significant difference when comparing IDH1 mutant overexpression or endogenous mutant inhibition to their respective controls. (PDF 64Â kb
Objective: A high percentage of grade II and III gliomas have mutations in the gene encoding isocitr...
Objective: A high percentage of grade II and III gliomas have mutations in the gene encoding isocitr...
Figure S5. IDH1 knockdown accelerated MCF7 cell proliferation and migration ability. (a) the express...
Effects of pharmacologic inhibition of the IDH1 mutant enzyme on TCA cycle intermediates. Cells were...
IDH1 mutant overexpression leads to high levels of 2-HG and the c227 inhibitor is an effective inhib...
Glucose labeling of metabolites. Glucose fractional contribution was computed for all 159 metabolite...
Patient-derived gliomasphere culture characteristics. Relevant patient information and clinical char...
2-HG inhibition with c227 moderately increases DNA damage following radiation but does not reverse t...
Radiation leads to low levels of TUNEL staining in gliomaspheres. Representative images and quantifi...
BackgroundThere is considerable interest in defining the metabolic abnormalities of IDH mutant tumor...
BackgroundThere is considerable interest in defining the metabolic abnormalities of IDH mutant tumor...
Figure S1. Simplified scheme of the examined bioenergetic pathways in the studied IDH1 wild-type and...
Contains fulltext : 167864.pdf (publisher's version ) (Open Access)The majority of...
Figure S3. IDH1 stable knockdown significantly promoted MDA-MB-231 cell motility. (a) The expression...
Objective: A high percentage of grade II and III gliomas have mutations in the gene encoding isocitr...
Objective: A high percentage of grade II and III gliomas have mutations in the gene encoding isocitr...
Objective: A high percentage of grade II and III gliomas have mutations in the gene encoding isocitr...
Figure S5. IDH1 knockdown accelerated MCF7 cell proliferation and migration ability. (a) the express...
Effects of pharmacologic inhibition of the IDH1 mutant enzyme on TCA cycle intermediates. Cells were...
IDH1 mutant overexpression leads to high levels of 2-HG and the c227 inhibitor is an effective inhib...
Glucose labeling of metabolites. Glucose fractional contribution was computed for all 159 metabolite...
Patient-derived gliomasphere culture characteristics. Relevant patient information and clinical char...
2-HG inhibition with c227 moderately increases DNA damage following radiation but does not reverse t...
Radiation leads to low levels of TUNEL staining in gliomaspheres. Representative images and quantifi...
BackgroundThere is considerable interest in defining the metabolic abnormalities of IDH mutant tumor...
BackgroundThere is considerable interest in defining the metabolic abnormalities of IDH mutant tumor...
Figure S1. Simplified scheme of the examined bioenergetic pathways in the studied IDH1 wild-type and...
Contains fulltext : 167864.pdf (publisher's version ) (Open Access)The majority of...
Figure S3. IDH1 stable knockdown significantly promoted MDA-MB-231 cell motility. (a) The expression...
Objective: A high percentage of grade II and III gliomas have mutations in the gene encoding isocitr...
Objective: A high percentage of grade II and III gliomas have mutations in the gene encoding isocitr...
Objective: A high percentage of grade II and III gliomas have mutations in the gene encoding isocitr...
Figure S5. IDH1 knockdown accelerated MCF7 cell proliferation and migration ability. (a) the express...